Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The life study Academic Article uri icon

Overview

MeSH Major

  • Antihypertensive Agents
  • Atenolol
  • Heart Failure
  • Hypertension
  • Hypertrophy, Left Ventricular
  • Losartan

abstract

  • Regression of time-varying Cornell product was associated with similar reductions in risk of new-onset HF and the combined endpoint of HF or death in ISH and non-ISH patients.

publication date

  • October 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1038/ajh.2012.86

PubMed ID

  • 22717544

Additional Document Info

start page

  • 1101

end page

  • 9

volume

  • 25

number

  • 10